These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura. Grillberger R; Casina VC; Turecek PL; Zheng XL; Rottensteiner H; Scheiflinger F Haematologica; 2014 Apr; 99(4):e58-60. PubMed ID: 24532042 [No Abstract] [Full Text] [Related]
8. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura. Thomas MR; de Groot R; Scully MA; Crawley JT EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702 [TBL] [Abstract][Full Text] [Related]
9. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura. Peyvandi F; Palla R; Lotta LA Haematologica; 2010 Sep; 95(9):1444-7. PubMed ID: 20807984 [No Abstract] [Full Text] [Related]
11. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238 [TBL] [Abstract][Full Text] [Related]